Index
1 Bioengineered Protein Drugs Market Overview
1.1 Bioengineered Protein Drugs Product Overview
1.2 Bioengineered Protein Drugs Market Segment by Type
1.2.1 Monoclonal Antibodies
1.2.2 Therapeutic Proteins
1.2.3 Vaccines
1.3 Global Bioengineered Protein Drugs Market Size by Type
1.3.1 Global Bioengineered Protein Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Bioengineered Protein Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Bioengineered Protein Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bioengineered Protein Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Bioengineered Protein Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Bioengineered Protein Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Bioengineered Protein Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Bioengineered Protein Drugs Sales Breakdown by Type (2018-2023)
2 Global Bioengineered Protein Drugs Market Competition by Company
2.1 Global Top Players by Bioengineered Protein Drugs Sales (2018-2023)
2.2 Global Top Players by Bioengineered Protein Drugs Revenue (2018-2023)
2.3 Global Top Players by Bioengineered Protein Drugs Price (2018-2023)
2.4 Global Top Manufacturers Bioengineered Protein Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bioengineered Protein Drugs Market Competitive Situation and Trends
2.5.1 Bioengineered Protein Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Bioengineered Protein Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bioengineered Protein Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Bioengineered Protein Drugs Market
2.8 Key Manufacturers Bioengineered Protein Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bioengineered Protein Drugs Status and Outlook by Region
3.1 Global Bioengineered Protein Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Bioengineered Protein Drugs Historic Market Size by Region
3.2.1 Global Bioengineered Protein Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Bioengineered Protein Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Bioengineered Protein Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Bioengineered Protein Drugs Forecasted Market Size by Region
3.3.1 Global Bioengineered Protein Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Bioengineered Protein Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Bioengineered Protein Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Bioengineered Protein Drugs by Application
4.1 Bioengineered Protein Drugs Market Segment by Application
4.1.1 Cancer
4.1.2 Diabetes
4.1.3 Autoimmune Disorder
4.1.4 Infectious Disease
4.1.5 Neurodegenerative
4.1.6 Others
4.2 Global Bioengineered Protein Drugs Market Size by Application
4.2.1 Global Bioengineered Protein Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Bioengineered Protein Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Bioengineered Protein Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bioengineered Protein Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Bioengineered Protein Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Bioengineered Protein Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Bioengineered Protein Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Bioengineered Protein Drugs Sales Breakdown by Application (2018-2023)
5 North America Bioengineered Protein Drugs by Country
5.1 North America Bioengineered Protein Drugs Historic Market Size by Country
5.1.1 North America Bioengineered Protein Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Bioengineered Protein Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Bioengineered Protein Drugs Sales in Value by Country (2018-2023)
5.2 North America Bioengineered Protein Drugs Forecasted Market Size by Country
5.2.1 North America Bioengineered Protein Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Bioengineered Protein Drugs Sales in Value by Country (2024-2029)
6 Europe Bioengineered Protein Drugs by Country
6.1 Europe Bioengineered Protein Drugs Historic Market Size by Country
6.1.1 Europe Bioengineered Protein Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Bioengineered Protein Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Bioengineered Protein Drugs Sales in Value by Country (2018-2023)
6.2 Europe Bioengineered Protein Drugs Forecasted Market Size by Country
6.2.1 Europe Bioengineered Protein Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Bioengineered Protein Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Bioengineered Protein Drugs by Region
7.1 Asia-Pacific Bioengineered Protein Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Bioengineered Protein Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Bioengineered Protein Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Bioengineered Protein Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Bioengineered Protein Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Bioengineered Protein Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Bioengineered Protein Drugs Sales in Value by Region (2024-2029)
8 Latin America Bioengineered Protein Drugs by Country
8.1 Latin America Bioengineered Protein Drugs Historic Market Size by Country
8.1.1 Latin America Bioengineered Protein Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Bioengineered Protein Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Bioengineered Protein Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Bioengineered Protein Drugs Forecasted Market Size by Country
8.2.1 Latin America Bioengineered Protein Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Bioengineered Protein Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Bioengineered Protein Drugs by Country
9.1 Middle East and Africa Bioengineered Protein Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Bioengineered Protein Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Bioengineered Protein Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Bioengineered Protein Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Bioengineered Protein Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Bioengineered Protein Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Bioengineered Protein Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Dr.Reddy’s
10.1.1 Dr.Reddy’s Company Information
10.1.2 Dr.Reddy’s Introduction and Business Overview
10.1.3 Dr.Reddy’s Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Dr.Reddy’s Bioengineered Protein Drugs Products Offered
10.1.5 Dr.Reddy’s Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Information
10.2.2 Eli Lilly Introduction and Business Overview
10.2.3 Eli Lilly Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Eli Lilly Bioengineered Protein Drugs Products Offered
10.2.5 Eli Lilly Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Bioengineered Protein Drugs Products Offered
10.3.5 Merck Recent Development
10.4 Reliance Life Sciences
10.4.1 Reliance Life Sciences Company Information
10.4.2 Reliance Life Sciences Introduction and Business Overview
10.4.3 Reliance Life Sciences Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Reliance Life Sciences Bioengineered Protein Drugs Products Offered
10.4.5 Reliance Life Sciences Recent Development
10.5 Panacea Biotech
10.5.1 Panacea Biotech Company Information
10.5.2 Panacea Biotech Introduction and Business Overview
10.5.3 Panacea Biotech Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Panacea Biotech Bioengineered Protein Drugs Products Offered
10.5.5 Panacea Biotech Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis Bioengineered Protein Drugs Products Offered
10.6.5 Novartis Recent Development
10.7 Fresenius
10.7.1 Fresenius Company Information
10.7.2 Fresenius Introduction and Business Overview
10.7.3 Fresenius Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Fresenius Bioengineered Protein Drugs Products Offered
10.7.5 Fresenius Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanofi Bioengineered Protein Drugs Products Offered
10.8.5 Sanofi Recent Development
10.9 ProBioGen
10.9.1 ProBioGen Company Information
10.9.2 ProBioGen Introduction and Business Overview
10.9.3 ProBioGen Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 ProBioGen Bioengineered Protein Drugs Products Offered
10.9.5 ProBioGen Recent Development
10.10 GlaxoSmithKline
10.10.1 GlaxoSmithKline Company Information
10.10.2 GlaxoSmithKline Introduction and Business Overview
10.10.3 GlaxoSmithKline Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 GlaxoSmithKline Bioengineered Protein Drugs Products Offered
10.10.5 GlaxoSmithKline Recent Development
10.11 Roche
10.11.1 Roche Company Information
10.11.2 Roche Introduction and Business Overview
10.11.3 Roche Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Roche Bioengineered Protein Drugs Products Offered
10.11.5 Roche Recent Development
10.12 Amoytop Biotech
10.12.1 Amoytop Biotech Company Information
10.12.2 Amoytop Biotech Introduction and Business Overview
10.12.3 Amoytop Biotech Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Amoytop Biotech Bioengineered Protein Drugs Products Offered
10.12.5 Amoytop Biotech Recent Development
10.13 Shanghai United Cell Biotechnology
10.13.1 Shanghai United Cell Biotechnology Company Information
10.13.2 Shanghai United Cell Biotechnology Introduction and Business Overview
10.13.3 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Products Offered
10.13.5 Shanghai United Cell Biotechnology Recent Development
10.14 Hualan Bio
10.14.1 Hualan Bio Company Information
10.14.2 Hualan Bio Introduction and Business Overview
10.14.3 Hualan Bio Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Hualan Bio Bioengineered Protein Drugs Products Offered
10.14.5 Hualan Bio Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bioengineered Protein Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bioengineered Protein Drugs Industrial Chain Analysis
11.4 Bioengineered Protein Drugs Market Dynamics
11.4.1 Bioengineered Protein Drugs Industry Trends
11.4.2 Bioengineered Protein Drugs Market Drivers
11.4.3 Bioengineered Protein Drugs Market Challenges
11.4.4 Bioengineered Protein Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bioengineered Protein Drugs Distributors
12.3 Bioengineered Protein Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer